Healthcare -
Biotechnology - NASDAQ - US
$ 23.44
0.171 %
$ 1.94 B
Market Cap
-14.84
P/E
Price Target
Average
134.64%
Revenue Forecast
Estimate
--13.29%
EBIT
Estimate
--7.63%
Net Income
Estimate
--20.57%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Beam Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for BEAM of $55 , with forecasts ranging from
a
low of
$39 to a high of $69 .
BEAM Lowest Price Target
Wall Street Target
39 USD
66.38%
BEAM Average Price Target
Wall Street Target
55 USD
134.64%
BEAM Highest Price Target
Wall Street Target
69 USD
194.37%
REVENUE FORECAST
Revenue Forecast Chart BEAM
EBIT FORECAST
EBIT Forecast Chart BEAM
NET INCOME FORECAST
Net Income Chart BEAM